Detalles de la búsqueda
1.
Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targets.
Int J Cancer
; 149(5): 1166-1180, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33890294
2.
Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).
BMC Cancer
; 20(1): 701, 2020 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727416
3.
Survival analysis of 287 oropharyngeal squamous cell carcinoma patients in a single institution: a retrospective comparison of two consecutive time intervals with surgical and conservative treatment approaches.
Eur Arch Otorhinolaryngol
; 274(8): 3211-3219, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28555274
4.
Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer.
Eur Arch Otorhinolaryngol
; 273(12): 4073-4080, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26755047
5.
Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria.
Ann Hematol
; 94(10): 1727-32, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26204824
6.
Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation.
Ann Hematol
; 93(5): 855-61, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24248672
7.
Src family kinase targeting in head and neck tumor cells using SU6656, PP2 and dasatinib.
Head Neck
; 45(1): 147-155, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36285353
8.
SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model.
Cells
; 12(13)2023 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37443832
9.
Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1.
Clin Transl Radiat Oncol
; 41: 100630, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37180052
10.
Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer.
Radiother Oncol
; 168: 138-146, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35093407
11.
Increased replication stress and R-loop accumulation in EGFRvIII-expressing glioblastoma present new therapeutic opportunities.
Neurooncol Adv
; 4(1): vdab180, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274102
12.
Rational surgical neck management in total laryngectomy for advanced stage laryngeal squamous cell carcinomas.
J Cancer Res Clin Oncol
; 147(2): 549-559, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32809056
13.
Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors.
Oral Oncol
; 123: 105603, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798574
14.
EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma.
Oncogene
; 39(15): 3041-3055, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32066879
15.
Receptor tyrosine kinase MET as potential target of multi-kinase inhibitor and radiosensitizer sorafenib in HNSCC.
Head Neck
; 41(1): 208-215, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30552828
16.
Analyzing expression and phosphorylation of the EGF receptor in HNSCC.
Sci Rep
; 9(1): 13564, 2019 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537844
17.
Axitinib: A Photoswitchable Approved Tyrosine Kinase Inhibitor.
ChemMedChem
; 13(22): 2415-2426, 2018 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30199151
18.
Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinoma: A subgroup analysis of the multicenter randomized clinical trial IMSTAR-HN.
Oral Oncol
; 126: 105733, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35093699
19.
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study.
Cancer Cell
; 40(6): 581-583, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35512712
Resultados
1 -
19
de 19
1
Próxima >
>>